Haemonetics Corp priced an offering of $600 million convertible senior notes due 2029 and entered into agreements to repurchase $200 million of its 0.00% Convertible Senior Notes due 2026.
AI Assistant
HAEMONETICS CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.